Clinical Study
The Soluble Plasminogen Activator Receptor as a Biomarker on Monitoring the Therapy Progress of Pulmonary TB-AFB(+) Patients
Table 1
Clinical data of patients included in the study.
| No | Patients’ characteristics | Frequency (n) | Percentage (%) |
| 1 | Number of patients | 20 | 100% | Male | 10 | 50% | | Female | 10 | 50% |
| 2 | Age (years); age median = 30 years | | | 19–30 | 12 | 60% | | 31–40 | 4 | 20% | | 41–50 | 4 | 20% |
| 3 | Width of lesion classification | | | Minimal lesion | 1 | 5% | Moderate advance lesion | 7 | 35% | | Far advance lesion | 12 | 60% |
| 4 | Patients’ complaints | | | Chronic cough 3 weeks | 20 | 100% | Decrease of appetite | 15 | 75% | Low grade fever | 10 | 50% | Shortness of breath | 9 | 45% | Hemoptoe | 9 | 45% | Chest pain | 2 | 10% |
|
|